Tarsier Pharma Ltd. (TARX)

We have not processed filings for Tarsier Pharma Ltd. yet. This page fills in on its own once we have read them.

What Tarsier Pharma Ltd. does

Tarsier Pharma Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).

Latest SEC filings

What Tarsier Pharma Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

July 16, 2026
IPO registration (foreign issuer) (amended) F-1/A
July 15, 2026
IPO registration (foreign issuer) (amended) F-1/A
June 16, 2026
IPO registration (foreign issuer) (amended) F-1/A
June 8, 2026
IPO registration (foreign issuer) (amended) F-1/A
May 18, 2026
Offering term sheet FWP
May 18, 2026
IPO registration (foreign issuer) (amended) F-1/A
April 21, 2026
IPO registration (foreign issuer) F-1

All filings on SEC EDGAR

Questions about TARX

What does Tarsier Pharma Ltd. do?

Tarsier Pharma Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).

When did Tarsier Pharma Ltd. last report?

Its newest filing of any kind is the iPO registration (foreign issuer) (amended) from July 16, 2026.

Similar companies

Follow TARX

Get an email when Tarsier Pharma Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow TARX: get an email when it files

Where the numbers come from

Financial figures are the values Tarsier Pharma Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.